Aktis Oncology Appoints Life Sciences Industry Veteran Mike Sherman To Its Board of Directors
August 7, 2025
Aktis Oncology, Inc., a clinical-stage company focused on advancing radiopharmaceutical therapies for cancers not addressed by current platforms, has announced that Mike Sherman has joined